Nimotuzumab combined cisplatin, 5-fluorouracil neoadjuvant chemotherapy follow by cisplatin synchronous intensity-modulated radiotherapy in locally advanced nasopharyngeal carcinoma: a multicenter, prospective phase II study
Latest Information Update: 25 May 2020
At a glance
- Drugs Cisplatin (Primary) ; Fluorouracil (Primary) ; Nimotuzumab (Primary) ; Docetaxel; Filgrastim; Ropidoxuridine
- Indications Carcinoma; Nasopharyngeal cancer
- Focus Adverse reactions; Therapeutic Use
- 27 Apr 2016 New trial record